Trials / Completed
CompletedNCT03685032
Effects of Intraoperative Dexamethasone and Ondansetron on Postoperative Nausea and Vomiting in Microvascular Decompression Surgery
Effects of Intraoperative Dexamethasone and Ondansetron on Postoperative Nausea and Vomiting in Microvascular Decompression Surgery: A Randomized Controlled Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 54 (actual)
- Sponsor
- Khon Kaen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Postoperative nausea and vomiting (PONV) is a common problem and may lead to catastrophic complications, especially in neurosurgical cases. The aim of this study was to evaluate the effects of dexamethasone and ondansetron for preventing PONV in patients who underwent microvascular decompression surgery (MVD).
Detailed description
A prospective, double-blinded randomized control trial was conducted with 54 patients who underwent MVD. Patients were allocated into two groups. The study group (Gr. D) received intraoperative dexamethasone 4 mg iv and ondansetron 4 mg iv, whereas the control group (Gr. N) received placebo (0.9% normal saline 1 ml iv and 0.9% normal saline 2 ml iv). The incidence and severity of PONV were observed at 1, 2, 4 and 24 hr post-surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexamethasone | The 4 mg of dexamethasone in 1 ml intravenous was administrated after patient received general anesthesia |
| DRUG | Ondansetron | The 4 mg of ondansetron in 2 ml intravenous was administrated at the end of the operation. |
| DRUG | 0.9% Sodium Chloride Injection | The 0.9% sodium chloride in 1 ml intravenous was administrated after patient received general anesthesia. At the end of operation, the 0.9% sodium chloride in 2 ml intravenous was administrated. |
Timeline
- Start date
- 2014-08-07
- Primary completion
- 2016-02-16
- Completion
- 2016-02-16
- First posted
- 2018-09-26
- Last updated
- 2018-09-26
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03685032. Inclusion in this directory is not an endorsement.